Company intelligence / Profile preview
NanoPharmaceuticals LLC
Rensselaer, New York, United Statesnanopharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
NanoPharmaceuticals is conducting a Phase 1 clinical trial of its lead compound fb-PMT in glioblastoma patients at Yale Cancer Center. Preclinical studies show broad anticancer activity with minimal side effects due to selective targeting of the αvβ3 integrin on tumor cells. Additional candidates are advancing toward trials in pancreatic cancer, AML, neuroblastoma, and non-cancer angiogenesis-related diseases.
- Therapeutic areas
- OncologyOphthalmology
- Modalities
- Small molecules (notably tetrac derivatives)Macromolecules targeting integrin receptors
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed as of latest available information.
Beyond the preview
Go deeper on NanoPharmaceuticals LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NanoPharmaceuticals LLC.